A Story of Immunization with Autologous IFN-γ Secreting Glioma Cells in Patients with Glioblastoma Multiforme is Safe and Prolongs Both Overall and Progress Free Survival

The study was a non-randomized controlled phase I-II trial to study were to ascertain the safety, feasibility and efficacy of immunotherapy with autologous IFN-γ transfected tumour cells in patients with glioblastoma multiforme. Autologous tumour cells harvested during surgery were cultured and tran...

Descripción completa

Detalles Bibliográficos

Autores principales:	G., Salford Leif, Siesjö, Peter, Skagerberg, Gunnar, Rydelius, Anna, Blennow, Catharina, Lilja, Åsa, Persson, Bertil Rolf Ragnar, Strömblad, Susanne, Visse, Edward, Widegren, Bengt
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2022
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/82094
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!